GM is developing anti-motion sickness tech for autonomous vehicles

General Motors (GM) has revealed details of its patent for anti-sickness technology which is being developed for use in autonomous vehicles (AV). GM is one of the largest car makers in the world; its daughter company Cruise has led the development of AVs. The documents, which were filed in July 2020, provide details of the new technology and how it will be implemented in AVs.
Source